Search results for "Infectious Diseases"
COVID-19 guideline update from NIH, postdischarge anticoagulation, remdesivir effects
The latest news on inpatient COVID-19 care includes some changes to the NIH guidelines for COVID-19 treatment, as well as studies showing that rivaroxaban after discharge reduced clots and remdesivir helped inpatients on no or low-flow oxygen but not those who were sicker.
https://acphospitalist.acponline.org/weekly/archives/2021/12/22/1.htm
22 Dec 2021
Beta-lactam plus doxycycline associated with lower mortality in older patients with CAP
Compared to other guideline-concordant empiric therapies for patients with community-acquired pneumonia (CAP), beta-lactam plus doxycycline was associated with lower 30-day and 90-day mortality in a Veterans Affairs cohort study.
https://acphospitalist.acponline.org/weekly/archives/2021/11/17/2.htm
17 Nov 2021
Latest studies look at pneumonia scores and stroke rates in inpatients with COVID-19
The PSI and CURB-65 work in patients with pneumonia from SARS-CoV-2, one study found, while another estimated stroke rates in COVID-19 inpatients. Research on breakthrough infections showed that full vaccination provided more protection than previous infection, among other findings.
https://acphospitalist.acponline.org/weekly/archives/2021/11/10/1.htm
10 Nov 2021
Heparin dosing for COVID-19 inpatients, expert perspectives on boosters
Two new trials offered some support for therapeutic anticoagulation in inpatients with elevated d-dimer levels. Antithrombotic therapy didn't prove helpful for outpatients with COVID-19. FDA advisors, an ACP/Annals forum, and recent research addressed vaccine effectiveness and boosters.
https://acphospitalist.acponline.org/weekly/archives/2021/10/20/1.htm
20 Oct 2021
Latest studies look at ECMO, prone positioning, antibodies, remdesivir
Mortality rates have risen among patients getting extracorporeal membrane oxygenation (ECMO) for COVID-19, one study found, while two others offered more evidence of the benefits of proning. Additional new research supported the use of monoclonal antibodies and remdesivir.
https://acphospitalist.acponline.org/weekly/archives/2021/10/06/1.htm
6 Oct 2021
Research, regulators consider booster dose of COVID-19 vaccine
In addition to booster shots, the latest COVID-19 research looked at vaccine effectiveness, remdesivir's effects, an early indicator of vaccine-induced immune thrombotic thrombocytopenia, and rates of follow-up after hospitalization.
https://acphospitalist.acponline.org/weekly/archives/2021/09/22/1.htm
22 Sep 2021
New COVID-19 treatment recommendations, data on vaccines and delta variant
The NIH updated its recommendations on inpatient treatment to address medication availability, metoprolol showed promise in a small ICU study, and new research highlighted decreased vaccine effectiveness and increased illness severity with the delta variant.
https://acphospitalist.acponline.org/weekly/archives/2021/09/01/1.htm
1 Sep 2021
Avoiding SNFs and antibiotics, expecting long-term effects and boosters in COVID-19
One study showed how a new committee reduced discharges to skilled nursing facilities (SNFs) while another indicated that empiric antibiotics aren't necessary for ventilated COVID-19 patients. Officials announced plans for vaccine boosters, and convalescent plasma failed an outpatient trial.
https://acphospitalist.acponline.org/weekly/archives/2021/08/25/1.htm
25 Aug 2021
Dexamethasone use, pandemic cardiac arrests and HAIs, latest COVID-19 vaccine news
Recent studies looked at use of dexamethasone and rates of in-hospital cardiac arrest in COVID-19 patients, hospital-acquired infections (HAIs) during the pandemic, and vaccine-induced immune thrombocytopenia. Also, the FDA and new research supported a third vaccine dose for organ transplant patients.
https://acphospitalist.acponline.org/weekly/archives/2021/08/18/1.htm
18 Aug 2021
Prediction rules for endocarditis in patients with Staphylococcus aureus bacteremia compared
In a Dutch study, one score (the VISTRA score) was considered safe for excluding endocarditis but could increase procedure use by classifying more patients as high risk.
https://acphospitalist.acponline.org/weekly/archives/2021/07/28/4.htm
28 Jul 2021